The Courier & Advertiser (Perth and Perthshire Edition)
Vaccines sold by GSK
GlaxoSmithKline has offloaded two of its meningitis vaccines to Pfizer Ireland Pharmaceuticals.
The deal for Nimenrix and Mencevax was forced by regulators for clearance of a wider three-part transaction between GSK and Novartis. The drugs generated £34 million in sales last year.